Skip to content

Validation of Access Rights

You wish to enter the website that  Alexion Pharma Nordics Holding AB (“Alexion Sweden”) has designated for the publication of documents and information in connection with Alexion Sweden’s recommended public cash offer to the shareholders of Wilson Therapeutics AB (“Wilson”) (the “Offer”).

In order to access further information in connection with the Offer, visitors to this website are requested to confirm notice and acceptance of the following legal information.

Enter the country in which you reside:

I am currently physically present in:

Next

Important information

Due to legal restrictions, the information on this website is not directed at or accessible to certain persons. We kindly ask you to review the following information each time you wish to access this website. Please note that the information and the terms set out below may be altered or updated and therefore it is important that you review them each time you visit this website.

On April 11th, 2018 Alexion Pharmaceuticals, Inc. (“Alexion”), through its wholly-owned subsidiary Alexion Pharma Nordics Holding AB (“Alexion Sweden”), announced a public cash offer to the shareholders in Wilson Therapeutics AB (“Wilson Therapeutics”) to acquire all shares in Wilson Therapeutics.

The Offer is not being made to persons whose participation in the Offer would require preparation of an additional offer document, registration, or any other measures in addition to those required under Swedish laws and regulations. No documentation relating to the Offer will be distributed and must not be mailed or otherwise distributed or sent in or into any country in which this would require any such additional measures to be taken or would be in conflict with any law or regulation in such country. Any such distribution will not be permitted or sanctioned by Alexion. Any purported acceptance of the Offer resulting directly or indirectly from a violation of these restrictions may be disregarded.

The Offer is not being and will not be made, directly or indirectly, in or into, or by use of mail or any other means or instrumentality of interstate or foreign commerce of, or any facilities of a national securities exchange of, Australia, Hong Kong, Japan, Canada, New Zealand or South Africa. This includes, but is not limited to facsimile transmission, e-mail, telex, telephone, the Internet and other forms of electronic transmission. The Offer cannot be accepted and shares may not be tendered in the Offer by any such use, means, instrumentality or facility of, or from within Australia, Hong Kong, Japan, Canada, New Zealand or South Africa or by persons located or resident in those jurisdictions. Accordingly, no information on this website nor any documentation relating to the Offer are not being and should not be mailed or otherwise transmitted, distributed, forwarded or sent in or into Australia, Hong Kong, Japan, Canada, New Zealand or South Africa or to any Australian, Hong Kongese, Japanese, Canadian, New Zealander or South African or any persons located or resident in Australia, Hong Kong, Japan, Canada, New Zealand or South Africa. Alexion will not deliver any consideration from the Offer into Australia, Hong Kong, Japan, Canada, New Zealand or South Africa.

Statements on this website relating to future status and circumstances, including statements regarding future performance, growth and other projections as well as benefits of the Offer, are forward-looking statements. These statements may generally, but not always, be identified by the use of words such as “anticipates”, “expects”, “believes”, or similar expressions. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There can be no assurance that actual results will not differ materially from those expressed or implied by these forward-looking statements due to many factors, many of which are outside the control of Alexion. Any such forward-looking statements speak only as of the date on which they were made and Alexion has no obligation (and undertakes no such obligation) to update or revise any of them, whether as a result of new information, future events or otherwise, except for in accordance with applicable laws and regulations.

By selecting "Yes, I confirm", you will confirm that you have read the information, the conditions and the instructions on this website and accept to be bound by them, and that you are not a resident of, nor located in, Australia, Hong Kong, Japan, Canada, New Zealand or South Africa, and that you are a person who is permitted under applicable law and regulation to access the information of the kind contained in this website.

“We are sorry, but the information on the requested pages is not intended for persons who are residents in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or are physically located in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa. You have not met this criteria or have not confirmed the necessary statements. You can therefore not access this page.”